6-110442247-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_033125.4(SLC22A16):āc.1180C>Gā(p.Leu394Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000049 in 1,613,118 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_033125.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC22A16 | NM_033125.4 | c.1180C>G | p.Leu394Val | missense_variant | 4/8 | ENST00000368919.8 | NP_149116.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC22A16 | ENST00000368919.8 | c.1180C>G | p.Leu394Val | missense_variant | 4/8 | 1 | NM_033125.4 | ENSP00000357915 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000250 AC: 38AN: 152140Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000679 AC: 17AN: 250240Hom.: 0 AF XY: 0.0000370 AC XY: 5AN XY: 135258
GnomAD4 exome AF: 0.0000219 AC: 32AN: 1460860Hom.: 0 Cov.: 31 AF XY: 0.00000963 AC XY: 7AN XY: 726644
GnomAD4 genome AF: 0.000309 AC: 47AN: 152258Hom.: 0 Cov.: 32 AF XY: 0.000336 AC XY: 25AN XY: 74430
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 16, 2023 | The c.1180C>G (p.L394V) alteration is located in exon 4 (coding exon 4) of the SLC22A16 gene. This alteration results from a C to G substitution at nucleotide position 1180, causing the leucine (L) at amino acid position 394 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at